Markets
Tendies
@tendies
Bought BLGO
Shares
down -8.66%
At 0.3, Exited 0.27
I believe BioLargo has a strong potential for growth, especially with the incoming AEC unit and the promising Clyra product. The expected uplist could...
Read
More
Thesis
I believe BioLargo has a strong potential for growth, especially with the incoming AEC unit and the promising Clyra product. The expected uplist could create significant upward momentum, and I'm ready to hold onto this stock for a period to capitalize on its advancements.
Go back
Tendies
@tendies
Bought BLGO
Shares
up 21.46%
At 0.22, Now 0.26
I just bought some BLGO today because I believe it's incredibly undervalued at a $65 million market cap, with projected 100% revenue growth this year ...
Read
More
Thesis
I just bought some BLGO today because I believe it's incredibly undervalued at a $65 million market cap, with projected 100% revenue growth this year and several catalysts ahead. This could be a solid long-term investment as it climbs back up due to its strong fundamentals.
Go back
Tendies
@tendies
Bought BLGO
Shares
up 47.32%
At 0.2, Exited 0.29
I see BioLargo as an exceptional buying opportunity right now with its market cap under $60 million and potential to double in value based on recent t...
Read
More
Thesis
I see BioLargo as an exceptional buying opportunity right now with its market cap under $60 million and potential to double in value based on recent technological advancements and a solid growth trajectory. The projected revenue growth and upcoming product launches, especially Clyra in Q1 2025, make it an attractive entry point.
Go back
Tendies
@tendies
Bought BLGO
Shares
up 11.36%
At 0.18, Exited 0.2
I'm investing in BioLargo right now because the stock is trading below $0.25, with huge growth potential due to its strong product performance and exp...
Read
More
Thesis
I'm investing in BioLargo right now because the stock is trading below $0.25, with huge growth potential due to its strong product performance and expanding market presence. The recent dips provide a great entry point, and I believe this stock could double based on upcoming revenue growth from their innovative subsidiaries.
Go back
Tendies
@tendies
Bought BLGO
Shares
up 36.27%
At 0.19, Now 0.26
I'm really excited about BioLargo and its AEC technology. With municipalities already signing contracts and the company's strong growth projections, I...
Read
More
Thesis
I'm really excited about BioLargo and its AEC technology. With municipalities already signing contracts and the company's strong growth projections, I believe investing now could lead to significant returns as they lead the way in addressing the PFAS crisis efficiently and cost-effectively.
Go back
Tendies
@tendies
Bought BLGO
Shares
down -4.85%
At 0.2, Exited 0.19
I just bought shares of BioLargo because their innovative products, especially POOPH, are crushing it in the market. With an expected $100 million cas...
Read
More
Thesis
I just bought shares of BioLargo because their innovative products, especially POOPH, are crushing it in the market. With an expected $100 million cash infusion on the horizon from potential sales, the growth prospects are massive and I believe the stock will continue to rise significantly.
Go back
Tendies
@tendies
Bought BLGO
Shares
up 6.86%
At 0.18, Exited 0.19
I'm really optimistic about BioLargo's future, especially with the Pooph product being a bestseller and the potential for major revenue from other sub...
Read
More
Thesis
I'm really optimistic about BioLargo's future, especially with the Pooph product being a bestseller and the potential for major revenue from other subsidiaries. I believe the current price is an excellent entry point before we see a significant rise as the company executes its growth plan.
Go back
Tendies
@tendies
Bought BLGO
Shares
down -9.62%
At 0.2, Exited 0.18
With an 80% year-over-year revenue growth and projections to continue at around 100%, I believe BioLargo is on the brink of significant gains. The upc...
Read
More
Thesis
With an 80% year-over-year revenue growth and projections to continue at around 100%, I believe BioLargo is on the brink of significant gains. The upcoming rollout of Clyra Medical Technologies' products adds to my confidence in holding this stock for a swing trade.
Go back
Tendies
@tendies
Bought BLGO
Shares
down -0.76%
At 0.24, Exited 0.24
I just bought into BioLargo (BLGO) because their recent validation of the Cellinity battery technology has really caught my attention. With the growin...
Read
More
Thesis
I just bought into BioLargo (BLGO) because their recent validation of the Cellinity battery technology has really caught my attention. With the growing demand for energy storage and their unique advantages over lithium-ion, I believe this stock is set to rise significantly as their tech gains traction in the market.
Go back
Tendies
@tendies
Bought BLGO
Shares
down -23.43%
At 0.24, Exited 0.19
With POOPH becoming the #1 bestseller on Amazon and Chewy, and retail presence set to quadruple, BLGO’s undervalued stock at under $70 million could s...
Read
More
Thesis
With POOPH becoming the #1 bestseller on Amazon and Chewy, and retail presence set to quadruple, BLGO’s undervalued stock at under $70 million could see substantial growth. The consistent 100% revenue growth for three consecutive years is poised to drive the stock higher.
Go back
Tendies
@tendies
Bought BLGO
Shares
down -9.71%
At 0.26, Exited 0.23
With BioLargo achieving a record quarterly revenue of $5 million and a significant 247% increase compared to last year’s second quarter, I believe the...
Read
More
Thesis
With BioLargo achieving a record quarterly revenue of $5 million and a significant 247% increase compared to last year’s second quarter, I believe their stock will continue to rise as they advance the commercialization of their cleantech products.
Go back
